Delivery Order SPE2DB24D2100-SPE2DB25FBDUV
Award Date 4/24/25
Potential Completion Date 5/15/25
Potential Value $75K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $102,754.09 for Ultomiris 300 mg/3 mL vials on September 15, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is scheduled for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $87,619.50 to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 mL vials. This contract is a firm fixed price delivery order with no set-aside designation, issued competitively on June 11, 2025, with an ultimate completion date of July 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $26,285.93 delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 300 mg/3 mL vials on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $50,978.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 ml vials. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a continuation of the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 6, 2025, for the supply of Ultomiris (periphakin alfa) 1,100 mg/11 ml vials under a firm fixed-price contract. The award, valued at $26,285.85 with a completion date of June 30, 2025, represents a non-competitive, non-set-aside delivery order issued by the Defense Logistics Agency's Medical Supply Chain. This contract is a child award under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,285.93 by the Defense Logistics Agency on July 18, 2025, for the supply of Ultomiris 300 mg/3 ml vials. This competitively awarded, firm fixed-price contract has no set-aside designation and is scheduled for completion by August 8, 2025. The award represents a child delivery order under AmerisourceBergen's broader relationship with the DLA, leveraging the company's established...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ultomiris (pegtibatimab alfa), a specialty pharmaceutical product, with a ceiling value of $26,285.85. This firm fixed-price delivery order is set to be completed by August 14, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $23,896.30 by the Defense Logistics Agency (DLA) for the supply of Ultomiris 300 mg/3 ml vials. The contract, awarded on September 12, 2025, carries an ultimate completion date of October 3, 2025, and represents a non-set-aside competitive award. As a child order under a larger contract vehicle, this delivery order fulfills DLA's medical supply procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $52,571.70 to AmerisourceBergen Drug Corp for the supply of Ultomiris (1,100 mg/11 mL vial), a pharmaceutical product for military healthcare needs. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 6, 2025, performed from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This delivery order, valued at $52,571.70 and awarded on September 19, 2025, provides Ultomiris (pegcetacoplan) 1,100 mg/11 mL vials to support federal medical procurement needs. The contract is a firm fixed price delivery order issued under a competitive, non-set-aside procurement process to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will be executed at the contractor's corporate office location in Conshohocken,...